Physician profile
Ellen D West
NPI 1336410893
$2,509.87
in general payments reported to CMS, 2019-2025
14 companies · $551 in 2025
The $551 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $156 · 2022: $998 · 2023: $372 · 2024: $433 · 2025: $551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,355.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $619.31 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $619.05 | 2021-2025 | Dupixent, Libtayo |
| Glaxosmithkline, LLC. | $598.88 | 2021-2025 | Nucala |
| Stryker Corporation | $219.83 | 2021-2025 | Scopis Ent |
| Alk-Abello, INC | $150.19 | 2022 | |
| Optinose US, INC. | $82.90 | 2021-2024 | |
| Genentech USA, INC. | $65.74 | 2021-2022 | |
| Phadia US INC. | $37.01 | 2021-2023 | Immunocap |
| Smith+Nephew, INC. | $28.48 | 2024 | Tula |
| Takeda Pharmaceuticals U.S.A., INC. | $25.68 | 2025 | Elaprase |
| Inspire Medical Systems, INC. | $21.20 | 2025 | Inspire |
| Hikma Pharmaceuticals USA | $14.93 | 2025 | Ryaltris |
| Astrazeneca Pharmaceuticals Lp | $14.06 | 2022 | |
| Merck Sharp & Dohme LLC | $12.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.